Загрузка...
THE RAPID ENROLLMENT DESIGN FOR PHASE I CLINICAL TRIALS
We propose a dose-finding design for Phase I oncology trials where each new patient is assigned to the dose most likely to be the target dose given observed data. The main model assumption is that the dose-toxicity curve is non-decreasing. This method is beneficial when it is desirable to assign a p...
Сохранить в:
| Опубликовано в: : | Stat Med |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4892992/ https://ncbi.nlm.nih.gov/pubmed/26833922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6886 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|